Abstract The clinical course of a Paroxysmal Nocturnal Hemoglobinuria (PNH) patient receiving treatment with terminal complement by ravulizumab and SARS-CoV2…
![](https://analesranm.es/wp-content/uploads/2018/08/user_hombre.jpg)
F. Ataulfo Gonzalez
Alexion Pharmaceuticals, Inc., Boston, MA
Abstract The clinical course of a Paroxysmal Nocturnal Hemoglobinuria (PNH) patient receiving treatment with terminal complement by ravulizumab and SARS-CoV2…